2749 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with recurrent or refractory ovarian cancer: A phase Ib trial reporting safety and clinical activity
Disis, M.L., Patel, M., Pant, S., Hamilton, E.P., Lockhart, A.C., Kelly, K., Thaddeus-Beck, J., Gordon, M., Weiss, G.J., Ejadi, S., Taylor, M.H., Chin, K., Cuillerot, J.M., Von Heydebreck, A., Gulley,Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31515-5
Date:
September, 2015
File:
PDF, 72 KB
english, 2015